Cancer Marker Profile - Prostate near me in Dombivli

Prostate cancer is one of the most commonly diagnosed cancers in men and often develops slowly. In its early stages, it may not cause noticeable symptoms, which makes laboratory testing an important part of risk assessment and ongoing monitoring. Prostate specific antigen (PSA) is a protein produced mainly by prostate cells and released into the blood in small amounts. When prostate tissue is altered due to cancer, inflammation, or enlargement, PSA levels may increase. In prostate cancer, abnormal cell growth can lead to higher PSA production or greater leakage of PSA into the bloodstream, making PSA a useful marker for evaluating prostate health when interpreted alongside clinical findings.

The Cancer Marker Profile - Prostate is a focused prostate cancer marker profile designed to support risk stratification, detection, and ongoing monitoring of prostate disorders. It includes Total PSA, which reflects the overall burden of prostate-derived antigen and serves as a monitoring marker; Free PSA, which helps distinguish benign prostatic conditions from malignancy when total PSA is borderline or moderately elevated; and the PSA Total/Free Ratio, which improves cancer risk prediction by indicating a higher likelihood of malignancy at lower ratios. Together, these parameters enhance diagnostic precision compared with total PSA alone and assist clinicians in deciding the need for further evaluation, such as imaging or biopsy. However, PSA markers are not cancer-specific and may be elevated in benign prostatic hyperplasia, prostatitis, recent instrumentation, or age-related changes; therefore, they should not be used as standalone diagnostic tests.

A doctor may suggest this profile for men undergoing evaluation for prostate cancer risk, those with abnormal digital rectal examination findings, or individuals requiring baseline assessment or follow-up monitoring during or after treatment. This profile is also useful for assessing disease progression and response to therapy when used alongside clinical findings.

No fasting is required for this test. Eat and drink as per your daily routine. Avoid sexual intercourse for 48 hours before the test. Inform your doctor about all the medications that you are taking at the moment. Do not take the test right after a prostate exam, biopsy, or catheter use, as these factors may cause a false increase in PSA levels.

Test results should always be interpreted by a doctor along with clinical evaluation and, if required, imaging or biopsy. Based on the results, further investigations or follow-up may be advised.